Muhammad Jawad Khan

COMSATS University Islamabad

Papers

1

Total Citations

339

H-Index

1

About

Muhammad Jawad Khan is a prominent researcher specializing in oncology and cancer therapeutics, with a particular focus on evaluating and advancing treatment modalities for one of the world's most pressing health challenges. His most notable contribution, a comprehensive 2025 review examining the advancements and limitations of traditional anti-cancer therapies, has already garnered an impressive 339 citations in a remarkably short period, underscoring its immediate and widespread influence within the scientific community. Khan's work critically examines the full spectrum of conventional cancer treatment approaches, including surgery, chemotherapy, radiation therapy, and hormonal therapy, providing researchers and clinicians with an authoritative synthesis of current capabilities and existing gaps. By situating these therapies within the broader context of tumor biology, his scholarship bridges fundamental cancer science with translational clinical applications, making it invaluable to both emerging and established researchers. His ability to identify where conventional treatments fall short while illuminating pathways for improvement reflects a deeply analytical approach to cancer research. For students and researchers navigating the complex landscape of oncology, Khan's work serves as an essential, highly regarded reference point for understanding where the field stands and where it must go.

Research Focus

Key Achievements

1
H-Index
1
Papers
339
Total Citations
339
Avg Citations/Paper
🏆 Most Cited Paper
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
339 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: COMSATS University Islamabad

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago